1. Home
  2. LXEO vs SEG Comparison

LXEO vs SEG Comparison

Compare LXEO & SEG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LXEO
  • SEG
  • Stock Information
  • Founded
  • LXEO 2017
  • SEG 2024
  • Country
  • LXEO United States
  • SEG United States
  • Employees
  • LXEO N/A
  • SEG N/A
  • Industry
  • LXEO
  • SEG
  • Sector
  • LXEO
  • SEG
  • Exchange
  • LXEO Nasdaq
  • SEG NYSE
  • Market Cap
  • LXEO 314.1M
  • SEG 362.3M
  • IPO Year
  • LXEO 2023
  • SEG N/A
  • Fundamental
  • Price
  • LXEO $6.24
  • SEG $30.70
  • Analyst Decision
  • LXEO Strong Buy
  • SEG
  • Analyst Count
  • LXEO 7
  • SEG 0
  • Target Price
  • LXEO $22.71
  • SEG N/A
  • AVG Volume (30 Days)
  • LXEO 623.4K
  • SEG 84.8K
  • Earning Date
  • LXEO 11-13-2024
  • SEG 11-07-2024
  • Dividend Yield
  • LXEO N/A
  • SEG N/A
  • EPS Growth
  • LXEO N/A
  • SEG N/A
  • EPS
  • LXEO N/A
  • SEG N/A
  • Revenue
  • LXEO N/A
  • SEG $111,487,000.00
  • Revenue This Year
  • LXEO N/A
  • SEG N/A
  • Revenue Next Year
  • LXEO N/A
  • SEG N/A
  • P/E Ratio
  • LXEO N/A
  • SEG N/A
  • Revenue Growth
  • LXEO N/A
  • SEG 36.09
  • 52 Week Low
  • LXEO $5.77
  • SEG $23.26
  • 52 Week High
  • LXEO $22.33
  • SEG $36.50
  • Technical
  • Relative Strength Index (RSI)
  • LXEO 28.99
  • SEG N/A
  • Support Level
  • LXEO $5.77
  • SEG N/A
  • Resistance Level
  • LXEO $11.72
  • SEG N/A
  • Average True Range (ATR)
  • LXEO 0.85
  • SEG 0.00
  • MACD
  • LXEO -0.19
  • SEG 0.00
  • Stochastic Oscillator
  • LXEO 5.71
  • SEG 0.00

About LXEO Lexeo Therapeutics Inc.

Lexeo Therapeutics Inc is a a clinical-stage genetic medicines company dedicated to transforming healthcare by applying pioneering science to fundamentally change how disease is treated. Its pipeline consists of candidates targeting patient populations that place significant burden on society and are most amenable to their genetic medicine approach. The Company is focused on preclinical and clinical stage gene therapies, and specifically on hereditary and acquired diseases of high unmet need which is their only business segment.

About SEG SEAPORT ENTERTAINMENT GROUP INC

Seaport Entertainment Group Inc own, operate and develop a unique collection of assets positioned at the intersection of entertainment and real estate. Its objective is to integrate one-of-a-kind real estate assets with a variety of restaurant, retail and leisure offerings to form vibrant mixed-use destinations where customers can work, play and socialize in one cohesive setting. The company has three operating segments: (1) Landlord Operations; (2) Hospitality; and (3) Sponsorships, Events, and Entertainment. Key revenue is generated from Landlord Operations which consists of the company's rental operations.

Share on Social Networks: